TheProfitWatch

CLYM - Climb Bio, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.72 -0.01 (-0.87%) 0.0 (-0.29%) 0.0 (-0.29%) 0.0 (0.29%) 0.0 (0.0%) -0.01 (-0.87%) 0.03 (1.77%) 0.03 (1.77%)

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.13
Diluted EPS:
-0.13
Basic P/E:
-13.1154
Diluted P/E:
-13.1154
RSI(14) 1m:
25.0
VWAP:
1.71
RVol:

Events

Period Kind Movement Occurred At

Related News